GENEVA, Sept. 18 -- JANSSEN PHARMACEUTICA NV filed a patent application (US2026/017944) for “INTERLEUKIN-23 RECEPTOR ANTAGONISTS FOR USE IN TREATING CROHN'S DISEASE”. With publication no. WO/2026/188058, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....